Study of Postoperative Ileus in Digestive Surgery

NCT ID: NCT06018961

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

161 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-24

Study Completion Date

2026-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post-operative ileus is a temporary stoppage of bowel function following surgery. Indeed it can occur in 20% of cases during post-operative follow-up of bowel surgery. The absence of resumption of transit can lead to the implementation of specific treatments such as the placement of a nasogastric tube and drug treatments. To date, the definition of this event is not accepted by everyone and is not based on reproducible evaluation criteria. The main objective of this study is to evaluate a score used to date to define postoperative ileus, the IFEED score, and to compare it to the length of postoperative stay.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postoperative ileus (also known as paralytic ileus) is defined as a temporary cessation of gastrointestinal peristalsis. This complication occurs mainly following gastrointestinal surgery. It can be noted that postoperative ileus also occurs postoperatively after pelvic and extra-abdominal surgery with a lower incidence. The incidence of ileus varies depending on the cohorts, however the rate of occurrence can be up to 20% post-operative colorectal surgery.The main principles of treatment are the fasting of the patient and the introduction of a nasogastric tube to ensure gastric emptying in order to prevent complications of vomiting such as bronchial aspiration. This pathological phenomenon is frequent and significantly lengthens the duration of hospitalization and postoperative morbidity and mortality. The duration of hospitalization is the only objective and reproducible criterion in the evaluation of ileus. One of the problems of postoperative ileus is first of all its evaluation and the implementation of a reproducible definition. A recent consensus conference of the American Society for Engaged Recovery and Perioperative Quality Initiative proposed a return definition of transit based on an IFEED (Intake-Feeling Nauseated-Emesis-Physical Exam-Duration of Symptoms) clinical score. However, this score has never been evaluated prospectively in a cohort of patients operated on for pathologies of the digestive tract. This is a descriptive, diagnostic, prospective, monocentric study. We will include patients entering our care sector for a gastrointestinal surgery. We will follow patient from the surgery to the end of their hospital stay.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Surgery

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Ileus Colorectal surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult patients with digestive surgery

Patients who have planned abdominal surgery

Post-operative ileus surgery

Intervention Type OTHER

Collection of ileus events, items of IFEED score and surgical complications

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Post-operative ileus surgery

Collection of ileus events, items of IFEED score and surgical complications

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient entering our care sector for surgical management of a pathology affecting the digestive tract:
* Colorectal cancer
* Chronic inflammatory bowel disease
* Colonic diverticulosis.

Exclusion Criteria

* Patient treated for digestive resection with associated resection procedure or to be treated with intraperitoneal chemotherapy.
* Patient presenting during hospitalization with an ileus secondary to another intra-abdominal complication.
* Patient cared for in an emergency
* Hepatic resection or other associated metastatic site
* Multiple digestive resection
* Colorectal anastomosis less than 7 cm from the anal margin (below the Pouch of Douglas)
* Patient with American Society of Anesthesiologists physical status (ASA) score \> 2
* Patient with an Eastern Cooperative Oncology Group (ECOG) Performance Status Scale \>2
* Pregnant or breastfeeding women
* Patient under a protection regime for adults (guardianship, curators, safeguard of justice)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role collaborator

University Hospital, Toulouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillaume LE COSQUER, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Toulouse

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Toulouse

Toulouse, , France

Site Status RECRUITING

INSERM

Toulouse, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guillaume LE COSQUER, MD

Role: CONTACT

Phone: 5 61 32 27 61

Email: [email protected]

Etienne BUSCAIL, MD-PhD

Role: CONTACT

Phone: 5 61 32 23 73

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Guillaume LE COSQUER, MD

Role: primary

Etienne BUSCAIL, MD-PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A02834-39

Identifier Type: OTHER

Identifier Source: secondary_id

RC31/22/0491

Identifier Type: -

Identifier Source: org_study_id